COMMUNIQUÉS West-GlobeNewswire

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
27/05/2026
WALTHAM, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF [...]
PREMIA and Lind Form Lind Asia to Expand AI-Powered Clinical Trial Screening Across Asia-Pacific
27/05/2026
Joint venture combines PREMIA’s regional clinical-genomic infrastructure with Lind’s evidence-driven AI platform to accelerate patient identification for multinational trials TAIPEI and SAN MATEO, Calif., May 27, 2026 ( [...]
Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
27/05/2026
Company remains on track for anticipated IND filing in Q3 2026, marking a transformative step toward becoming a clinical-stage biotechnology company CAMBRIDGE, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics [...]
Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
27/05/2026
Conexeu to leverage WFIRM's advanced tissue-organ bioprinting infrastructure to evaluate the durability, integration, and resorbability of proprietary CXU™ 3D-printed matrix technology RENO, Nev., May 27, 2026 (GLOBE [...]
TOMI Environmental Solutions Highlights Expanded Market Opportunity Following CDC-Published Hantavirus Study and Rising Global Ebola Concerns
27/05/2026
WHO-flagged Ebola outbreak and rising hantavirus exposure risks underscore growing institutional demand for scalable, hospital-grade decontamination solutions across healthcare, hospitality, transportation, and [...]
EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients
27/05/2026
MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”, the “Company”) an innovative clinical-stage biotechnology company focused on developing transformative treatments [...]
Altimmune to Participate in Upcoming Investor Conferences
27/05/2026
GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that [...]
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
27/05/2026
Comprehensive Cancer Screening Initiative Expected to Generate Approximately $500,000 in Testing Revenues to 20/20 from the First Cohort GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- 20/20 Biolabs, Inc. (Nasdaq: [...]
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
27/05/2026
ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today [...]
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
27/05/2026
Broad-spectrum antiviral agent with potential utility against Hantavirus, Ebola and Lassa Utilizing a novel dual-strike mechanism, the proprietary combination agent has the potential to deliver a low pill burden option [...]
AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
27/05/2026
Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following infection in a mouse model following lethal doses of Ebola Company to release Virtual Investor “Ebola: What [...]
Omada Health to Participate in Goldman Sachs Global Healthcare Conference
27/05/2026
SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Goldman Sachs 47th [...]
Palisade Bio to Participate in the Jefferies Global Healthcare Conference
27/05/2026
Management presentation to take place on Thursday, June 4 th at 3:45 PM ET Register for the webcast here Denver, CO, May 27, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a [...]
Privia Health Enters New Jersey
27/05/2026
Represents 25th State in National Primary Care-Centric Care Delivery Network ARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced [...]
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
27/05/2026
IRVINE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy ® Transcatheter Heart Valve (THV) System, today announced the appointment of Edward (Ed) Sarnowski [...]
AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates
27/05/2026
AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation technologies. For IND-enabling programs, conjugation process development timelines can be as short [...]
Southern California Reproductive Center Joins Nucleus IVF+ Network as Patient Demand Accelerates
27/05/2026
The move brings Genetic Optimization to one of the most sought-after fertility clinics in the U.S., following Nucleus’ rapid global expansion across 160+ clinics NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Nucleus [...]
Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting
27/05/2026
Six ASCO abstracts and an industry expert theater session underscore Myriad’s leadership in the cancer care continuum SALT LAKE CITY, May 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in [...]
MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
27/05/2026
New analyses examine Afrezza across pediatric A1c and efficacy, patient treatment satisfaction, use with AID algorithms and investigator-led research in pregnancy Late-breaking comparative data vs. rapid-acting insulin [...]

Pages